BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 19, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
May 20, 2015
View Archived Issues
Galectin Therapeutics finds no drug-drug interaction between GR-MD-02 and midazolam
Read More
Merck & Co. funds Canadian research institute collaborations
Read More
Mochida and Merck & Co. terminate diabetes collaboration
Read More
Epirus licenses Latin American rights to infliximab biosimilar to mAbxience
Read More
Lilly and Sanford-Burnham collaborate on immunological therapies
Read More
DoD contract provides funding for AcelRx's development of ARX-04
Read More
Eisai offers overview of fourth quarter of fiscal 2014
Read More
RadioMedix and AREVA Med to codevelop treatment for neuroendocrine tumors
Read More
Bristol-Myers Squibb divulges inhibitors of HIV replication
Read More
ARHGEF15 shows potential as a prognosic biomarker for PDAC
Read More
Serum FGF-21 as a highly sensitive biomarker for early diagnosis of breast cancer
Read More
HedgePath receives investment from Mayne Pharma and plans SUBA-Itraconazole trial
Read More
Sorrento Therapeutics focuses on immuno-oncology and resiniferatoxin for cancer pain
Read More
ADDF grant supports Oryzon's development of ORY-2001 for Alzheimer's disease
Read More
Novel approach to identify aggressive susceptibility genes in prostate cancer
Read More
Oncolytics Biotech's Reolysin cleared to start pediatric phase I trial in brain tumors
Read More
Tacrolimus shows efficacy as the first medical therapy for cherubism
Read More
Debiopharm reports results of phase III trial of triptorelin in central precocious puberty
Read More
STAT-3 inhibitors: a promising therapy to treat necrotizing enterocolitis
Read More
Janssen and Achillion establish global HCV collaboration
Read More
French investigators patent chimeric proteins for amyloidosis
Read More
Medivir discloses RSV replication inhibitors
Read More
Bayer Schering Pharma presents BUB1 inhibitors
Read More
Sunshine Lake Pharma develops FFAR1 agonists
Read More
Prima BioMed releases final data from phase II ovarian cancer study of CVac
Read More
Full results of DELOS trial of idebenone in DMD reported
Read More
Invega Trinza approved in U.S. for 3-monthly treatment of schizophrenia
Read More